Log in

OTCMKTS:NEPHNephros Stock Price, Forecast & News

$8.05
-0.02 (-0.25 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.90
Now: $8.05
$8.13
50-Day Range
$7.07
MA: $7.94
$8.56
52-Week Range
$4.42
Now: $8.05
$11.35
Volume2,801 shs
Average Volume14,534 shs
Market Capitalization$72.51 million
P/E RatioN/A
Dividend YieldN/A
Beta0.85
Nephros, Inc., a commercial stage medical device and commercial product company, develops and sells liquid purification filters and hemodiafiltration (HDF) systems primarily in the United States. It operates through two segments, Water Filtration and Renal Products. The company's ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from water borne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It offers HDF systems for use in conjunction with a hemodialysis machine that enables nephrologists to provide HDF treatment to patients with end stage renal disease; hemodiafilters for use as dialyzers in hemodialysis treatment; and water filters to food service, hospitality, and convenience store markets under the AETHER brand name. The company was founded in 1997 and is headquartered in South Orange, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.83 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NEPH
Previous SymbolNASDAQ:NEPH
CUSIPN/A
Phone201-343-5202

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.69 million
Book Value$0.89 per share

Profitability

Net Income$-3,400,000.00

Miscellaneous

Employees18
Market Cap$72.51 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NEPH News and Ratings via Email

Sign-up to receive the latest news and ratings for NEPH and its competitors with MarketBeat's FREE daily newsletter.

Nephros (OTCMKTS:NEPH) Frequently Asked Questions

How has Nephros' stock been impacted by COVID-19 (Coronavirus)?

Nephros' stock was trading at $7.47 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NEPH stock has increased by 7.8% and is now trading at $8.05. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Nephros?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nephros in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nephros.

How were Nephros' earnings last quarter?

Nephros, Inc. (OTCMKTS:NEPH) released its quarterly earnings results on Wednesday, May, 6th. The company reported ($0.13) EPS for the quarter, missing the Zacks' consensus estimate of ($0.09) by $0.04. The company had revenue of $2.53 million for the quarter. Nephros had a negative net margin of 49.93% and a negative return on equity of 56.37%. View Nephros' earnings history.

What price target have analysts set for NEPH?

2 brokers have issued 1 year price targets for Nephros' stock. Their forecasts range from $16.00 to $16.00. On average, they expect Nephros' stock price to reach $16.00 in the next twelve months. This suggests a possible upside of 98.8% from the stock's current price. View analysts' price targets for Nephros.

Has Nephros been receiving favorable news coverage?

Headlines about NEPH stock have trended negative recently, InfoTrie reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nephros earned a coverage optimism score of -2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Nephros.

Who are some of Nephros' key competitors?

What other stocks do shareholders of Nephros own?

Who are Nephros' key executives?

Nephros' management team includes the following people:
  • Mr. Daron G. Evans, Pres, CEO & Director (Age 45)
  • Mr. Andrew Astor, CFO & COO (Age 62)
  • Ms. Joleen C. Turner, VP of Marketing & Bus. Devel.

What is Nephros' stock symbol?

Nephros trades on the OTCMKTS under the ticker symbol "NEPH."

How do I buy shares of Nephros?

Shares of NEPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nephros' stock price today?

One share of NEPH stock can currently be purchased for approximately $8.05.

How big of a company is Nephros?

Nephros has a market capitalization of $72.51 million and generates $5.69 million in revenue each year. The company earns $-3,400,000.00 in net income (profit) each year or ($0.54) on an earnings per share basis. Nephros employs 18 workers across the globe.

What is Nephros' official website?

The official website for Nephros is www.nephros.com.

How can I contact Nephros?

Nephros' mailing address is 380 LACKAWANNA PLACE, SOUTH ORANGE NJ, 07079. The company can be reached via phone at 201-343-5202.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.